KRAS and benign colon neoplasm: Furthermore, it was suggested that RASAL1 functions in the progression of benign colonic neoplasms.[70] Therefore, in subjects who are at risk for CRC and bear benign polyps in their intestine containing mutated KRAS genes, upregulation of this gene could lead to progression to advanced malignant lesions.